Centrica plc (LON:CNA – Get Free Report) insider Chris O?Shea purchased 99 shares of the business’s stock in a transaction that occurred on Thursday, September 10th. The shares were purchased at an average price of GBX 152 per share, for a total transaction of £150.48.
Centrica Stock Down 0.1%
CNA stock traded down GBX 0.20 during trading on Friday, reaching GBX 150.75. The stock had a trading volume of 1,058,018,500 shares, compared to its average volume of 40,663,953. The company has a quick ratio of 0.40, a current ratio of 1.43 and a debt-to-equity ratio of 80.68. The company has a market capitalization of £6.83 billion, a price-to-earnings ratio of 9.98, a P/E/G ratio of 0.45 and a beta of 0.32. Centrica plc has a one year low of GBX 146.79 and a one year high of GBX 220.30. The company’s 50 day moving average is GBX 159.77 and its two-hundred day moving average is GBX 184.15.
Centrica (LON:CNA – Get Free Report) last posted its earnings results on Thursday, July 23rd. The integrated energy company reported GBX 6.80 EPS for the quarter. Centrica had a net margin of 3.64% and a return on equity of 21.92%.
Wall Street Analyst Weigh In
View Our Latest Analysis on CNA
Centrica Company Profile
Centrica is energising a greener, fairer future for our colleagues, customers and communities. Our integrated business operates across the energy value chain, with over ten million Retail customers, leading brands such as British Gas and Bord Gáis Energy, and the UK’s largest energy services workforce. Our Infrastructure businesses bring gas and electricity to the market every day and provide more than half of the UK’s gas storage capacity, while our Optimisation business delivers world-class procurement and route-to-market capabilities to the Group and third parties, supporting energy security and our customers’ decarbonisation journeys.
See Also
- Five stocks we like better than Centrica
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Centrica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centrica and related companies with MarketBeat.com's FREE daily email newsletter.
